Clinical trial · Interventional
Development and Implementation of Electronic Decision Aids for Genetic Testing in Inherited Cancer Syndromes
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
An electronic decision aid will be used to assist individuals in choosing a multi-gene panel with their medical oncologist instead of a genetic counselor. A decision aid may facilitate quality decisions around the selection of a specific multi-gene panel without a genetic counselor. Upon completion of the decision aid, participants will be asked to indicate their decision about whether to pursue genetic testing and which specific multi-gene panel to pursue. A survey will then be administered to assess participants' opinions on the decision aid.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Genetic Testing | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Survey of Decision Aid | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- Electronic Decision Aid
- description
- Participants in this arm will complete an electronic decision aid for genetic testing.
- interventionNames
- Other: Survey of Decision Aid
Primary outcomes (1)
- measure
- Participant Satisfaction With How Educational Information is Presented in the Decision Aid
- timeFrame
- This outcome will be measured immediately following completion of the decision aid. The average completion time of the decision aid is 14 minutes.
- description
- Measured with 6 items on a questionnaire that asks participants to rate the way certain information is presented on the decision aid. Each item is rated on a scale of 1 to 4, with 1 being poor and 4 being excellent.
Secondary outcomes (1)
- measure
- Total Time Spent on Decision Aid
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Adults (18 years of age or older) * Diagnosed with malignant ovarian tumor or malignant pancreatic adenocarcinoma Exclusion Criteria: * Children (\<18 years of age) * Unable to complete surveys * Previous germline genetic testing
References
Publications (0)
Data not yet available